Agios Pharmaceuticals Inc
SWB:8AP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Agios Pharmaceuticals Inc
SWB:8AP
|
US |
|
M
|
Microchip Technology Inc
XHAM:MCP
|
US |
|
Beigene Ltd
NASDAQ:ONC
|
KY |
|
Suncorp Group Ltd
ASX:SUN
|
AU |
|
H
|
Healius Ltd
F:PGZ
|
AU |
|
F
|
Fresnillo PLC
F:FNL
|
MX |
|
P
|
Pegasystems Inc
XBER:PEA
|
US |
|
A
|
Archean Chemical Industries Ltd
BSE:543657
|
IN |
|
Dana Inc
NYSE:DAN
|
US |
|
Sealsq Corp
F:8OE
|
CH |
|
B
|
Bank CIMB Niaga Tbk PT
IDX:BNGA
|
ID |
|
T
|
Twilio Inc
SWB:TWH
|
US |
|
M
|
Meiji Holdings Co Ltd
DUS:3M0
|
JP |
|
Beigene Ltd
F:49B
|
KY |
|
R
|
Redbubble Ltd
F:WAB
|
AU |
|
A
|
Alphabet Inc
F:ABEC
|
US |
|
UPL Ltd
LSE:UPLL
|
IN |
|
Comer Industries SpA
F:X5Q
|
IT |
|
RTL Group SA
F:RRTL
|
LU |
|
Couchbase Inc
F:1V3
|
US |
Bankruptcy Probability
Agios Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Agios Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
1.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
381.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Agios Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Agios Pharmaceuticals Inc has no debt.
You can find a full breakdown on its Balance Sheet.
